UNSPSC 85602504: Revision of nonautologous tissue substitute in large intestine, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in large intestine, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DWE7KZ

UNSPSC 85602504 Revision of nonautologous tissue substitute in large intestine, via natural or artificial opening is a Commodity code with minimal recent state and local procurement activity directly aligned to its nominal scope. The six recent opportunities tagged to this code span occupational medical surveillance, disability medical evaluation services, surgical benefit carve-out programs, pharmacy benefit management, emergency and specialty medical services for detained youth, and temporary health professional staffing — none of which involve tissue substitutes or gastrointestinal procedures. The code shows little relevant recent activity; the mismatch between the code's clinical procedure focus and the actual work being procured suggests either misclassification by the issuing bodies or a disconnect between the UNSPSC taxonomy and the health-related services state and local governments are actually buying right now.

Issuing bodies tagging this code include state departments (Washington State Department of Transportation on behalf of Washington State Ferries), county health systems and departments (Santa Clara Health System, Harris County Juvenile Probation Department, Collier County), city retirement and benefits offices (City of Phoenix Retirement Office, City of Long Beach), and special-purpose districts (Collier County Health Care Consortium). If this code were actively used for its stated purpose, buyers would include state health agencies, hospital systems, and county medical procurement offices; the current distribution suggests misapplication rather than genuine procurement under the tissue-substitute taxonomy. Geographic spread across Washington, Arizona, California, Florida, and Texas reflects the general geography of the recent opportunities, but this distribution does not signal an active market for the code's actual scope. Pursuing opportunities tagged to this code requires careful pre-bid vetting to confirm whether the stated scope aligns with what each issuing body is actually buying.